CEIB - Centre Interfacultaire des Biomatériaux - ULiège
Disciplines :
Materials science & engineering
Author, co-author :
Wang, Y.
Molin, D.
Sevrin, Chantal ; Université de Liège > Centre interfacultaire des biomatériaux (CEIB)
Grandfils, Christian ; Université de Liège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, et biochimie humaine
van den Akker, Nyncke
Gagliardi, M.
Knetsch, M.L.
Delhaas, T.
Koole, L.
Language :
English
Title :
In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy
Publication date :
2016
Journal title :
International Journal of Pharmaceutics
ISSN :
0378-5173
eISSN :
1873-3476
Publisher :
Elsevier Science, Amsterdam, Netherlands
Volume :
503
Pages :
150–162
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
Biomimedics
Funders :
DG RDT - Commission Européenne. Direction Générale de la Recherche et de l'Innovation [BE]
O. Abdel-Rahman, and Z.A. Elsayed Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature Dig. Dis. Sci 58 2013 3389 3396
T. Boulikas, and M. Vougiouka Cisplatin and platinum drugs at the molecular level Oncol. Rep 10 2003 1663 1682 (Review)
G. Carpentier, M. Martinelli, J. Courty, and I. Cascone Angiogenesis analyzer for ImageJ 4th ImageJ User and Developer Conference Proceedings 2012 198 201 (ISBN: 2-919941-18-6)
V. Cepeda, M.A. Fuertes, J. Castilla, C. Alonso, C. Quevedo, and J.M. Perez Biochemical mechanisms of cisplatin cytotoxicity Anticancer Agents Med. Chem. 7 2007 3 18
Y.S. Chang, J. Adnane, P.A. Trail, J. Levy, A. Henderson, D. Xue, E. Bortolon, M. Ichetovkin, C. Chen, A. McNabola, D. Wilkie, C.A. Carter, I.C. Taylor, M. Lynch, and S. Wilhelm Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models Cancer Chemother. Pharmacol. 59 2007 561 574
S. Dasari, and P.B. Tchounwou Cisplatin in cancer therapy: molecular mechanisms of action Eur. J. Pharmacol. 740 2014 364 378
C. Davis, T. Boyett, and J. Caridi Renal artery embolization: application and success in patients with renal cell carcinoma and angiomyolipoma Semin. Intervent. Radiol. 24 2007 111 116
A. Erhardt, F. Kolligs, M. Dollinger, E. Schott, H. Wege, M. Bitzer, C. Gog, F. Lammert, M. Schuchmann, C. Walter, D. Blondin, C. Ohmann, and D. Häussinger TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter: phase II SOCRATES trial Cancer Chemother. Pharmacol. 74 2014 947 954
A.M. Florea, and D. Büsselberg Cisplatin as an anti-tumor drug: cellular mechanisms of activity: drug resistance and induced side effects Cancers 3 2011 1351 1371
J. Folkman Role of angiogenesis in tumor growth and metastasis Semin. Oncol. 29 2002 15 18
S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review Int. J. Pharm. 415 2011 34 52
M.A. Fuertes, J. Castilla, C. Alonso, and J.M. Perez Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways Curr. Med. Chem. 10 2003 257 266
R. Graeser, U. Fiedler, N. Esser, A. Klotzbuecher, H. Weber, and C. Schaechtele The potency of refined mouse models: implications for clinical trials Curr. Cancer Ther. Rev. 6 2010 62 80
I. Grizzi, H. Garreau, S. Li, and M. Vert Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence Biomaterials 16 1995 305 311
H.K. Kim, and T.G. Park Comparative study on sustained release of human growth hormone from semi-crystalline poly(l-lactic acid) and amorphous poly(d,l-lactic-co-glycolic acid) microspheres: morphological effect on protein release J. Control. Release 98 2004 115 125
J. Lammer, K. Malagari, T. Vogl, F. Pilleul, A. Denys, A. Watkinson, M. Pitton, G. Sergent, T. Pfammatter, S. Terraz, Y. Benhamou, Y. Avajon, T. Gruenberger, M. Pomoni, H. Langenberger, M. Schuchmann, J. Dumortier, C. Mueller, P. Chevallier, and R. Lencioni Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc. Intervent. Radiol. 33 2010 41 52
A.J. Lasprilla, G.A. Martinez, B.H. Lunelli, A.L. Jardini, and R.M. Filho Poly-lactic acid synthesis for application in biomedical devices - a review Biotechnol. Adv. 30 2012 321 328
A.L. Lewis, R.R. Taylor, B. Hall, M.V. Gonzalez, S.L. Willis, and P.W. Stratford Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J. Vasc. Interv. Radiol. 17 2006 1335 1343
A.L. Lewis DC Bead: a major development in the toolbox for the interventional oncologist Expert Rev. Med. Devices 6 2009 389 400
W.-I. Li, K.W. Anderson, R.C. Mehta, and P.P. Deluca Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method J. Control. Release 37 1995 199 214
E. Liapi, and J.F. Geschwind Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc. Intervent. Radiol. 34 2011 37 49
L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter 2006. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res. 66 2006 11851 11858
K. Malagari, M. Pomoni, A. Kelekis, A. Pomoni, S. Dourakis, T. Spyridopoulos, H. Moschouris, E. Emmanouil, S. Rizos, and D. Kelekis Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma Cardiovasc. Interv. Radiol. 33 2010 541 551
Y. Mao, E.T. Keller, D.H. Garfield, K. Shen, and J. Wang Stromal cells in tumor microenvironment and breast cancer Cancer Metastasis Rev. 32 2013 303 315
J.W. McGinity, and P.B. O'Donnell Preparation of microspheres by the solvent evaporation technique Adv. Drug Deliv. Rev. 28 1997 25 42
P. Moroz, S.K. Jones, J. Winter, and B.N. Gray Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model J. Surg. Oncol. 78 2001 22 29
N. Nitta, S. Ohta, A. Sonoda, S. Watanabe, H. Otani, Y. Tomozawa, A. Nitta-Seko, K. Tsuchiya, K. Mukaisho, M. Takahashi, K. Murata, and Y. Tabata Evaluation of the embolic effect and degradability of gelatin microspheres and Gelpart particles Minim. Invasive Ther. Allied Technol. 22 2013 157 164
S. Ohta, N. Nitta, A. Sonoda, A. Seko, T. Tanaka, M. Takahashi, S. Takemura, Y. Tabata, and K. Murata Prolonged local persistence of cisplatin-loaded gelatin microspheres and their chemoembolic anti-cancer effect in rabbits Eur. J. Radiol. 72 2009 534 540
T.G. Park, H. Yong Lee, and Y. Sung Nam A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study J. Control. Release 55 1998 181 191
T.G. Park Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight J. Control. Release 30 1994 161 173
C.G. Pitt, F.I. Chasalow, Y.M. Hibionada, D.M. Klimas, and A. Schindler Aliphatic polyesters: I. The degradation of poly(ε-caprolactone) in vivo J. Appl. Polym. Sci. 26 1981 3779 3787
C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles, and A. Schindler Aliphatic polyesters II. The degradation of poly (DL-lactide) poly (epsilon-caprolactone), and their copolymers in vivo Biomaterials 2 1981 215 220
D.F. Quail, and J.A. Joyce Microenvironmental regulation of tumor progression and metastasis Nat. Med. 19 2013 1423 1437
T.K. Rhee, J.Y. Young, A.C. Larson, G.K. Haines, K.T. Sato, R. Salem, M.F. Mulcahy, L.M. Kulik, T. Paunesku, and G.E. Woloschak Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1α in rabbit VX2 liver tumors J. Vasc. Interv. Radiol. 18 2007 639 645
A.J. Richardson, J.M. Laurence, and V.W. Lam Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review J. Vasc. Interv. Radiol. 24 2013 1209 1217
C. Senturk, V. Cakir, K. Yorukoglu, O. Yilmaz, and A.Y. Goktay Looking for the ideal particle: an experimental embolization study Cardiovasc. Intervent. Radiol. 33 2010 336 345
P. Simamora, and W. Chern Poly-l-lactic acid: an overview J. Drugs Dermatol. 5 2006 436 440
D. Strumberg, J.W. Clark, A. Awada, M.J. Moore, H. Richly, A. Hendlisz, H.W. Hirte, J.P. Eder, H.-J. Lenz, and B. Schwartz Safety pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors Oncologist 12 2007 426 437
W.I. Sundquist, K.J. Ahmed, L.S. Hollis, and S.J. Lippard Solvolysis reactions of cis- and trans-diamminedichloroplatinum(II) in dimethyl sulfoxide: structural characterization and DNA binding of trans-bis(ammine) chloro(DMSO) platinum(1+) Inorg. Chem. 26 1987 1524 1528
S. Tardito, C. Isella, E. Medico, L. Marchio, E. Bevilacqua, M. Hatzoglou, O. Bussolati, and R. Franchi-Gazzola The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells J. Biol. Chem. 284 2009 24306 24319
H. Tian, Z. Tang, X. Zhuang, X. Chen, and X. Jing Biodegradable synthetic polymers: preparation: functionalization and biomedical application Prog. Polym. Sci. 37 2012 237 280
M. Varela, M.I. Real, M. Burrel, A. Forner, M. Sala, M. Brunet, C. Ayuso, L. Castells, X. Montana, J.M. Llovet, and J. Bruix Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J. Hepatol. 46 2007 474 481
S. Virmani, T.K. Rhee, R.K. Ryu, K.T. Sato, R.J. Lewandowski, M.F. Mulcahy, L.M. Kulik, B. Szolc-Kowalska, G.E. Woloschak, and G.Y. Yang Comparison of hypoxia-inducible factor-1α expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors J. Vasc. Interv. Radiol. 19 2008 1483 1489
Y. Wang, N.M. van den Akker, D.G. Molin, M. Gagliardi, C. van der Marel, M. Lutz, M.L. Knetsch, and L.H. Koole A nontoxic additive to introduce x-ray contrast into poly(lactic acid) Implications for transient medical implants such as bioresorbable coronary vascular scaffolds Adv. Healthc. Mater. 3 2014 290 299
Y. Wang, A. Benzina, D.G. Molin, N. Akker, M. Gagliardi, and L.H. Koole Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy J. Biomater. Sci. Polym. Ed. 26 2015 77 91
L. Weng, N. Rostambeigi, N.D. Zantek, P. Rostamzadeh, M. Bravo, J. Carey, and J. Golzarian An in situ forming biodegradable hydrogel-based embolic agent for interventional therapies Acta. Biomater. 9 2013 8182 8191
L. Weng, P. Rostamzadeh, N. Nooryshokry, H.C. Le, and J. Golzarian In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release Acta. Biomater. 9 2013 6823 6833
S.M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, H. Rong, C. Chen, X. Zhang, P. Vincent, M. McHugh, Y. Cao, J. Shujath, S. Gawlak, D. Eveleigh, B. Rowley, L. Liu, L. Adnane, M. Lynch, D. Auclair, I. Taylor, R. Gedrich, A. Voznesensky, B. Riedl, L.E. Post, G. Bollag, and P.A. Trail BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis Cancer Res. 64 2004 7099 7109
Q. Yang, S. Zhang, M. Kang, R. Dong, and J. Zhao Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells Oncol. Rep. 33 2015 2537 2544
L. Zhang, P. Hu, X. Chen, and P. Bie Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis PLoS One 2014 9
